ReviewThe oncologist2018

The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars.

Jennifer R Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.